Key PointsQuestion
Could traditional dietary patterns effectively address the complex relationship between environmental sustainability and the incidence of diet-related diseases like metabolic syndrome?
Findings
In this secondary analysis of a cluster randomized clinical trial including 574 participants, a traditional Atlantic dietary intervention significantly reduced the incidence of metabolic syndrome. There was no statistically significant difference in the reduction in dietary carbon footprint emissions in the intervention group compared with the control group.
Meaning
These findings suggest that traditional diets could serve as valuable tools to promote the convergence of human and planetary health, making them noteworthy models of sustainable and healthy dietary patterns.
Importance
The universal call to action for healthier and more sustainable dietary choices is the framework of the United Nations’s Sustainable Development Goals. The Atlantic diet, originating from the northwest of the Iberian Peninsula, represents an example of a traditional diet that aligns with these principles.
Objective
To explore a 6-month intervention based on the Atlantic diet’s effects on metabolic and environmental health, assessing metabolic syndrome (MetS) incidence and the carbon footprint.
Design, Setting, and Participants
The Galician Atlantic Diet study was a 6-month randomized clinical trial designed to assess the effects of this regional traditional diet on families’ eating habits. The study was conducted from March 3, 2014, to May 29, 2015, at a local primary health care center in the rural town of A Estrada in northwestern Spain and involved a multisectoral collaboration. Families were randomly selected from National Health System records and randomized 1:1 to an intervention or control group. This secondary analysis of the trial findings was performed between March 24, 2021, and November 7, 2023.
Interventions
Over 6 months, families in the intervention group received educational sessions, cooking classes, written supporting material, and foods characteristic of the Atlantic diet, whereas those randomized to the control group continued with their habitual lifestyle.
Main Outcomes and Measures
The main outcomes were MetS incidence, defined per National Cholesterol Education Program Adult Treatment Panel III guidelines, and carbon footprint emissions as an environmental metric using life cycle assessment with daily dietary intake as the functional unit.
Results
Initially, 250 families were randomized (574 participants; mean [SD] age, 46.8 [15.7] years; 231 males [40.2%] and 343 females [59.8%]). The intervention group included 126 families (287 participants) and the control group, 124 families (287 participants). Ultimately, 231 families completed the trial. The intervention significantly reduced the risk of incident cases of MetS (rate ratio, 0.32; 95% CI, 0.13-0.79) and had fewer MetS components (proportional odds ratio, 0.58; 95% CI, 0.42-0.82) compared with the control condition. The intervention group did not have a significantly reduced environmental impact in terms of carbon footprint emissions compared with the control group (−0.17 [95% CI, −0.46 to 0.12] kg CO2 equivalents/person/d).
Conclusions and Relevance
These findings provide important evidence that a family-focused dietary intervention based on a traditional diet can reduce the risk of incident MetS. Further research is needed to understand the underlying mechanisms and determine the generalizability to other populations, taking into account regional cultural and dietary variations.
Trial Registration
ClinicalTrials.gov Identifier: NCT02391701
Diets worldwide are changing, often with a negative impact on human and planetary health. To achieve the United Nations’s Sustainable Development Goals (SDGs) on noncommunicable disease reduction (SDG 3) and climate change mitigation (SDG 13), a shift to sustainable, healthy dietary patterns is necessary.1 These diets should support health and be environmentally friendly, accessible, affordable, safe, equitable, and culturally acceptable.1 Some traditional regional diets, such as the Atlantic diet, align with this concept. The Atlantic diet shares similarities with the Mediterranean diet and has been linked to lower metabolic risk factors2-6 and environmental benefits.7
We hypothesize that a shift to a traditional Atlantic diet would not only improve population health but also contribute to the sustainability of the environment, while taking into account the identity and diversity of the food system and culture of northwest Spain and northern Portugal. To date, no clinical trial has been conducted that assesses the effects of a traditional diet (ie, the Atlantic diet) from a dual-sustainability perspective on human and environmental health, thus addressing 2 of the United Nations’s SDGs. Therefore, in this report, we address 2 questions: (1) whether an intervention based on a traditional Atlantic diet can reduce the incidence of new cases of metabolic syndrome (MetS) or contribute to a higher resolution of existing cases compared with a general population and (2) whether this intervention would result in a lower environmental impact.
This study is a post hoc secondary analysis of the Galicia Atlantic Diet (GALIAT) study, a 6-month, community-focused randomized clinical trial designed to assess the effects of the traditional Atlantic diet on metabolic health and dietary habits in families. The GALIAT trial was performed from March 3, 2014, to May 29, 2015, at the local primary health care center in the rural town of A Estrada in northwestern Spain. This trial was grounded in the traditional diet of the study area and entailed a collaborative, multisectoral approach involving citizens, local businesses, researchers, and public institutions.8 The trial was deliberately shaped to be pragmatic, prioritizing effectiveness and practicality in primary care settings.9
Study procedures are detailed in previous publications,6,8 and the study protocol is provided in Supplement 1. The Galacian Autonomic Committee for Research Ethics approved the trial (code 2013/531) and the current study. During the preassessment session, participants were briefed on the project’s objectives, informed about subject selection methods, given detailed information on participation requirements, and acquainted with their rights as participants. Additionally, comprehensive project documentation, along with informed consent forms for all family members (including adults, children, and guardians) were provided. Participants who chose to participate further were then scheduled for an initial evaluation at the health center where, accompanied by their families, they submitted signed informed consent forms and underwent evaluations to confirm compliance with the inclusion/exclusion criteria. The trial was performed in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. The study was retrospectively registered with ClinicalTrials.gov (NCT02391701) and followed the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines10 and the Template for Intervention Description and Replication (TIDieR) checklist.11 The current data analysis was performed between March 24, 2021, and November 7, 2023.
Recruitment within the community was performed through a random representative sample of 3500 individuals, aged 18 to 85 years and stratified by decades of age, drawn from the Spanish National Health System Register of a single rural population of approximately 20 000 inhabitants. These index individuals and their household family members were invited to participate if they lived in a family unit of at least 2 members aged 3 to 85 years; were not currently taking lipid-lowering medication; were not pregnant; and did not have alcoholism,12 major cardiovascular disease, dementia, or a life expectancy of less than 1 year, which specifically refers to individuals with a terminal disease (Supplement 1). The study comprised participants of Spanish ethnicity and Caucasian descent. Fieldwork personnel gathered data on the specific birthplaces and family histories of the participants.
Randomization and Procedures
Families were randomly assigned in a 1:1 ratio to the intervention or control group using a computer-generated random number table. The dietary intervention was based on the Atlantic diet, the traditional diet in northwestern Spain and Portugal, which is composed of local, fresh, and minimally processed seasonal foods like vegetables, fruits, whole grains, beans, and olive oil. The Atlantic diet also features high fish and seafood consumption, along with starch-based products, dried fruits (particularly chestnuts), milk, cheese, and moderate meat and wine intake.8,13
The dietary counseling aimed to modify food habits in accordance with the characteristics of the Atlantic diet but not necessarily to restrict energy intake. Dietary recommendations were adapted to conform to the preferences and nutritional needs of each participant. In the intervention group, families attended 3 nutrition education sessions at the health care center and received additional support, including a cooking class, written materials, and regular food baskets with traditional Atlantic diet items (eFigure 1 in Supplement 2). Control group participants were advised to maintain their usual lifestyle. Previous articles assessed dietary patterns, with baseline values showing similarity (eMethods in Supplement 2).9
At the baseline and after 6 months, information was collected on dietary intake, physical activity,14 medication use, and other variables. Masking procedures were implemented at the randomization and data entry stages to minimize potential biases. However, due to the nature and design of our study, masking at the intervention level was not feasible.
Metabolic syndrome was defined according to criteria from the National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines15 and based on meeting at least 3 of the following 5 criteria: (1) waist circumference greater than 102 cm for men or greater than 88 cm for women, (2) triglyceride levels of 150 mg/dL or higher (≥1.7 mmol/L), (3) high-density lipoprotein cholesterol less than 40 mg/dL (<1.03 mmol/L) for men or less than 50 mg/dL (<1.3 mmol/L) for women, (4) blood pressure of 130/85 mm Hg or higher, and (5) fasting glucose level of 110 mg/dL or higher (≥6.2 mmol/L). Participants who were being treated with antidiabetic, antihypertensive, or triglyceride-lowering medications were classified as positive for the respective criterion. We investigated (1) whether the intervention can reduce the incidence of new cases (among those participants without MetS at baseline) and (2) whether there were differences in the prevalence of MetS and its components (among all-comers) at the end of follow-up between the intervention and control groups.
Metabolic variables were measured at the primary health care center. All anthropometric measurements were made in triplicate (eMethods in Supplement 2).
A 3-day food diary was used to collect dietary intake data (eMethods in Supplement 2). Nutritionists verified all records completed by participants in their presence. Dietary intake was analyzed using DIAL, version 3.3.5.0 professional nutrition analysis software.16
Life cycle assessment (LCA) is a method of quantifying the environmental impacts of the life cycle of products, processes, or services.17 The most common environmental impact category assessed in LCA is the carbon footprint, the best-known indicator of climate change.
The LCA approach was used to calculate each participant’s dietary carbon footprint, relative to a functional unit, as a baseline for all calculations. The functional unit chosen was individual daily dietary intake based on the results of the dietary questionnaires.
The carbon footprint framework assessed CO2 emissions associated with each participant’s diet. This well-established indicator was used while considering variations in LCA study boundaries. Our approach focused on the life cycle from food production to household consumption, with adjustments for supply chain food losses and waste (eMethods and eFigure 2 in Supplement 2).18-23
Sample size was determined for the primary outcome (Supplement 1). Analyses were conducted for the intention-to-treat population, with missing data imputed using the multivariable imputation by chained equations method.24 The main analysis used multiple imputation using Markov chain Monte Carlo method with 30 imputations for each missing measurement. A per-protocol sensitivity analysis was also performed. Baseline comparability was assessed using χ2 tests (categorical variables) and Student t tests (continuous variables). Modified Poisson regressions with robust error variance were used to estimate rate ratios (RRs) and their 95% CIs for new MetS cases (in participants without MetS) in the intervention group compared with the control group25 after adjusting for age and sex. For exploratory purposes, point prevalences (with 95% CIs) for MetS and its components at baseline and after 6 months were estimated.
Cumulative logit regression models for ordered categories were constructed to examine the effect of the intervention on the number of MetS risk factors as an ordinal variable ranked from 0 to 5 compared with control condition. Mixed-effects linear models were used to evaluate changes in carbon footprint emissions from baseline to the 6-month follow-up in all randomized participants, as well as in those who completed the study. These models were adjusted for age, sex, and baseline values, with intervention as a fixed effect and family as the random effect. The intraclass correlation coefficient (ICC) was calculated to examine how much variance in the carbon footprint outcome was explained by the family cluster effect. All analyses were conducted using Stata, version 16.0 statistical software (StataCorp LLC). The χ2 test was used for differences between categorical variables, and the Student t test for continuous variables. All statistical tests were 2-sided, and P < .05 was deemed statistically significant.
Of 250 families (720 participants) who were recruited and randomized, a total of 121 families (270 adults [aged ≥18 years]) in the intervention group and 110 (248 adults) in the control group completed the trial (Figure 1). Briefly, all participants were White, the mean (SD) number of persons per family unit was 2.3 (0.8), the mean (SD) participant age was 46.8 (15.7) years, and 231 participants (40.2%) were male and 343 (59.8%) female. As previously reported,6 the randomization produced 2 groups with similar characteristics of baseline sociodemographic and potential confounding factors, including education, smoking, alcohol intake, and physical activity, with the exception of age, which was significantly higher in the intervention group (mean [SD], 48.2 [15.8] vs 45.3 [15.4] years for the intervention and control groups, respectively) (Table 1). All individuals in the intervention group participated in the nutrition education program. A total of 241 of 287 (84.0%) participants in the intervention arm and 238 of 287 (82.9%) in the control group filled out the 3-day food record completely at baseline and 6 months.
Effect of the GALIAT Intervention on MetS and Its Components
Of the 457 participants without MetS at the beginning of the trial, 23 developed MetS during the 6-month follow-up (6 [2.7%] in the intervention group; 17 [7.3%] in the control group). There was a significant reduction in incident MetS cases for the intervention group (RR, 0.32; 95% CI, 0.13-0.79) compared with the control group (Table 2).
Initially, 117 participants (20.4%) met the ATP III criteria for MetS, with 63 (22.0%) in the intervention group and 54 (18.8%) in the control group (Figure 2). After the 6-month follow-up, 18 participants in the intervention group (28.6%) and 16 (29.6%) in the control group no longer met these criteria. Therefore, in the whole sample (eg, participants with and without MetS), the intervention was not significantly associated with a reduced risk in overall MetS prevalence (RR, 0.82; 95% CI, 0.64-1.06) (Table 2). The most common MetS features were abdominal obesity (46.0%; 95% CI, 41.9%-50.1%) and high blood pressure (45.3%; 41.2%-49.4%). The intervention group saw a significant decrease in waist circumference (mean [SD] change, −1.79 [0.40] cm; P < .001) but no significant decreases in blood pressure (systolic: mean [SD] change, −1.4 [1.0] mmHg [P = .17]; diastolic: mean [SD] change, −0.72 [0.64] mmHg [P = .27]).
For individual MetS components, the intervention reduced the risk of central obesity (RR, 0.90; 95% CI, 0.82-1.00) and low high-density lipoprotein cholesterol (RR, 0.79; 95% CI, 0.64-0.97) compared with the control condition (Table 2). The intervention had no significant effect on high blood pressure, high triglyceride levels, or high fasting serum glucose levels compared with the control condition. Additional modeling details are provided in eTable 5 in Supplement 3. Per-protocol analysis showed similar results, with the exception of a significant reduction in hypertension risk associated with the intervention (eTable 1 in Supplement 2).
Multivariable ordered logistic regression analysis revealed that participants in the intervention group had a proportional odds ratio of 0.58 (95% CI, 0.42-0.82) for having more MetS components compared with those in the control group (Table 3), which means that those in the intervention group were approximately 42% less likely to exhibit an additional MetS component compared with the control group. Sensitivity analysis using the per-protocol population showed similar results in magnitude and direction (eTable 2 in Supplement 2).
Effect of the GALIAT Intervention on Carbon Footprint Emissions
After 6 months, the carbon footprint score was reduced in the control group (baseline: mean [SD], 3.71 [1.55] kg CO2 equivalents [kgCO2eq]/person/d; after 6 months: mean [SD], 3.56 [1.50] kgCO2eq/person/d) and the intervention group (baseline: mean [SD], 3.60 [1.44] kgCO2eq/person/d; after 6 months: mean [SD], 3.38 [1.39] kgCO2eq/ person/d) (eTable 3 and eFigure 3 in Supplement 2). Linear mixed regression analysis did not show a significant between-group difference (−0.17 kgCO2eq/person/d; 95% CI, −0.46 to 0.12), after adjusting for baseline values, age, and sex and with family as the random effect. The sensitivity analysis for the carbon footprint using the per-protocol population showed similar results (eTable 4 in Supplement 2). The ICC revealed that approximately 45% of the variability in the carbon footprint score was due to family membership, revealing the importance of the family belongingness in the emission of greenhouse gases associated with food.
In a community-based sample from the GALIAT randomized clinical trial, we jointly examined the effects of a nutritional intervention based on a traditional Atlantic diet on MetS and associated changes in its components and the environmental outcomes associated with the Atlantic diet in terms of carbon footprint. Our main finding was that the 6-month nutritional intervention showed a lower risk of developing MetS among participants in the intervention group compared with the control group. Furthermore, individuals in the intervention group were approximately 42% less likely to exhibit an additional MetS component than those in the control group, although there was no evidence of a reduction in the RRs of high blood pressure, hypertriglyceridemia, or hyperglycemia, separately. Finally, the comparison between food consumption in the intervention and control groups did not achieve a statistically significant reduction in environmental impact.
Our study provides important contributions to the field. First, the positive outcomes for MetS and carbon footprint emissions were observed in a community-based sample following a diet that aligns with their cultural heritage. Second, the evidence provided for a randomized clinical trial that includes environmental parameters offers unique and valuable insight into how traditional diets can promote both health outcomes and environmental sustainability in line with the United Nations’s 2030 Agenda.26 Finally, the ICCs indicate that the cluster (family) factor had an important influence on the mean change of greenhouse gas emissions, supporting the effectiveness of family-based approaches for mitigating the impact of food-related greenhouse gas emissions.
It is well established that weight loss has a great benefit for the treatment of all the components of the MetS, which are excessive adiposity, dyslipidemia, hypertension, insulin resistance, and hyperglycemia.27-30 Approximately 20% of the study participants had MetS at baseline, consistent with the prevalence observed in a large study of 24 670 individuals from the general Spanish population, aged 35 to 74 years, without diabetes or cardiovascular disease.31 Similarly, our study’s findings on abdominal obesity closely match the 51% prevalence reported in a sample of 17 980 individuals aged 18 to 80 years in Spain according to ATP III criteria.32
On the other hand, our study is also critical to understanding the implications of dietary choices on environment-related SDGs, especially SDG 13 (health and climate action). This relationship was shown through the randomized controlled nutritional intervention, where we observed a reduction of 0.17 kgCO2eq/person/d in the intervention group compared with the control group. We believe that the lack of statistical significance can be attributed to the study’s limited statistical power, since the sample size was primarily determined to detect changes in cholesterol levels (Supplement 1). We have estimated that a study with approximately 2000 participants would be necessary for this reduction to reach statistical significance with a P < .05. Therefore, the observed outcome supports our expectation that adherence to the Atlantic diet in the broader target population could significantly enhance the carbon footprint metric, contributing to efforts to achieve net-zero CO2 emissions by 2050 in line with SDG 13.33
These findings are broadly consistent with research showing that the traditional Atlantic diet is a climate-friendly diet, well ranked under environmental criteria.7 Moreover, results from previous work that mainly focused on carbon footprint emissions of the Atlantic diet based on bibliographic recommendations7,18 fall within the range of our average carbon footprint calculated for the intervention group after 6 months, taking into consideration associated deviations. For example, González-García et al7 designed a dietary scenario based on serving sizes as defined by the Spanish Society of Community Nutrition and data on current food consumption in Galician households and obtained a carbon footprint for the Atlantic diet of 3.62 kgCO2eq/person/d.
Strengths and Limitations
This study has several strengths, including a randomized design, high retention rates, objective clinical and environmental measures, and a representative random sample from the general population. Our data offer valuable clinical insight into MetS and its prevention in a population-based context. We intentionally chose a community with moderate socioeconomic and educational levels to enhance generalizability, aligning with Organisation for Economic Co-operation and Development indicators at the time of study design.34 Baseline data suggest minimal bias, as randomization resulted in only slight group differences.
The study also has several limitations. Various unknown factors aside from the dietary intervention could have influenced clinical outcomes. In addition, the study intervention was complex, and it is not possible to determine which actions of the intervention may have contributed to the results. Thus, unmeasured aspects may exist. Contamination bias might be present, as the study received media attention, potentially influencing individuals’ lifestyles. The strategy of providing food baskets served as an incentive for session attendance and adherence but may limit generalizability to populations with food access challenges. The broad variety of carbon footprint emissions usually reported in published LCAs of food products, together with the diversity of food items in participant data, could have contributed to the environmental outcome. Moreover, 6 months may not have been long enough to properly assess metabolic changes. Follow-up of participants over a number of years could strengthen our results. Finally, our study’s sample size might lack the statistical power required to detect a significant reduction in CO2 emissions, indicating a potential need for larger-scale studies.
As far as we are aware, the GALIAT study is the first community-based randomized clinical trial that, taking into account the identity and diversity of the region’s food system and culture, has shown the positive effect of a traditional diet intervention on the incidence of new cases of MetS, as well as on limiting greenhouse gas emissions. Our findings provide important evidence for the potential of traditional diets to accelerate progress toward achieving SDGs. Further research is needed to thoroughly understand the underlying mechanisms behind the observed outcomes and to determine the generalizability of these findings to other populations, taking into account the cultural and dietary variations of each region.
Accepted for Publication: December 11, 2023.
Published: February 7, 2024. doi:10.1001/jamanetworkopen.2023.54473
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Cambeses-Franco C et al. JAMA Network Open.
Corresponding Author: Mar Calvo-Malvar, PhD, Department of Laboratory Medicine, University Clinical Hospital of Santiago de Compostela, Tr Choupana s/n, Santiago de Compostela, La Coruña 15706, Spain (mariadelmar.calvo.malvar@sergas.es).
Author Contributions: Profs Gude and Calvo-Malvar had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Gude, Leis, Sánchez-Castro, Moreira, Calvo-Malvar.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Cambeses-Franco, Gudes, Calvo-Malvar.
Critical review of the manuscript for important intellectual content: All authors.
Statistical analysis: Gudes, Benítez-Estévez, Sánchez-Castro.
Obtained funding: Benítez-Estévez, Leis, Calvo-Malvar.
Administrative, technical, or material support: Cambeses-Franco, Gudes, Benítez-Estévez, González-García, Leis, Sánchez-Castro, Calvo-Malvar.
Supervision: Cambeses-Franco, Gudes, Benítez-Estévez, González-García, Leis, Moreira, Feijoo, Calvo-Malvar.
Conflict of Interest Disclosures: None reported.
Funding/Support: This project was funded by grants ITC-20133014 and ITC-20151009 from the Regional Development Fund Interconecta for Galicia Program managed by the Centre for the Development of Industrial Technology, Spanish Ministry of Economy, Industry and Competitiveness.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Data Sharing Statement: See Supplement 4.
Additional Contributions: Collaborating researchers from the A Estrada Primary Care Center were as follows: Mercedes Berdullas-Silva, MD; Serafín Bartolomé-Perez, MD; María Elena Díaz-Malaguilla-Agustín, MD; Esther Diéguez-Soengas, MD; José Antonio Dono-López, MD; Manuel Fernández-Arean, MD; Miguel Fernández-Gago, MD; Carmen Fernández-Merino, Gerardo García-Freijeiro, PhD; María Del Carmen García-Iglesias, MD; Josefa Gerpe-Jamardo, MD; José Antonio Gonzalo-Vives, MD; Luis Meijide-Calvo, MD; Fernando Pampín-Conde, MD; Jesus Pereiras-Bernárdez, MD; Juan Sánchez-Castro, MD; Daniel Rey-Aldana, MD; Jesus Rey-García, MD; Luis Sanmartín-Portas, MD; Carmen Túñez-Bastida, MD; Isabel Díaz-Cardama-Sousa, MD; Mónica Picón-Cotos, MD; Manuel Pumarega-Vergara, MD; Amelia Agra-Alvarez, RN; Luisa Amigo-Souto, RN; Carmen Baloira Nogueira, RN; Fernanda Beceiro-Díaz, RN; Pilar Brea-López, RN; Josefina Escariz-Torres, RN; Teresa Fernández-Gestoso, RN; Monserrat Garrido-Garrido, RN; Elsa Junquera-Sánchez, RN; Francisca López-López, RN; Elisa Martínez-Bestilleiro, RN; María Teresa Matalobos-Luis, RN; Soledad Molano-Mateos, RN; Amalia Pais-Andrade, RN; Carmen Pernas-Rodríguez, RN; María Antonia Puges-Dorca, RN; Concepción Ramos-Durán, RN; Dolores Rodríguez-Figueiras, RN; Francisca Soneira-Soneira, RN; Concepción Temes-Coto, RN; María del Carmen Bermúdez-Virgós; Eva De La Calle-López; Patricia García-Torre; Juan Francisco Gestoso-Pazo; Paula Pedreira-Cajaraville; Manuel Angel Rey-Ferreiro; Eva Vale-Baltar; and María José Vizoso-Saborido. All collaborating researchers participated in the study without charging any fees, purely motivated by altruism. The authors thank the following groups for their scientific support: Viticulture Group at the Biological Mission of Galicia (Spanish National Research Council [CSIC]); Brassica Breeding Group at the Biological Mission of Galicia (CSIC); Marine Products Chemistry Group (Marine Research Institute CSIC Vigo); Department of Pharmacology, Faculty of Medicine, University of Santiago de Compostela; Lactic Products Unit, University of Santiago de Compostela; and Agro-environmental and Food Research Group, Department of Analytical and Alimentary Chemistry, University of Vigo. The authors also thank the participating companies for involvement in the provision of the food baskets, including Bodegas Terras Gauda, Bodegas Pazo de Rivas, Conservas A Rosaleira, Conservas Friscos, Aceites Olei, and Quescrem, and the other individuals, businesses, and organizations of A Estrada that assisted in this study, including A Estrada City Council, Belarmino Fernández Iglesias Hostelry School, Sala Gradín Restaurant, A Estrada Congress and Exhibition Foundation, Radio A Estrada, local press. Finally, the authors thank the participating families, without whom this research would not have been possible. Mrs Cambeses-Franco and Profs González-García, Moreira, and Feijoo belong to the Galician Competitive Research Group (GRC ED431C 2017/29) and to the Cross-Disciplinary Research in Environmental Technologies (CRETUS Research Center, ED431E 2018/01). Mrs Cambeses-Franco thanks the Ministry of Science, Innovation and Universities for financial support (grant reference FPU 19/06648). All these programs are cofunded by European Regional Development Fund (European Union). Mrs Cambeses-Franco’s scholarship was not used for or associated with this specific study or the broader GALIAT study.
1.World Health Organization. Sustainable Healthy Diets: Guiding Principles. Food & Agriculture Org; 2019.
3.Moreira
C, Santos
R, Moreira
P,
et al. Cardiorespiratory fitness is negatively associated with metabolic risk factors independently of the adherence to a healthy dietary pattern.
Nutr Metab Cardiovasc Dis. 2013;23(7):670-676. doi:
10.1016/j.numecd.2012.01.011
PubMedGoogle ScholarCrossref 5.Rodríguez-Martín
C, Garcia-Ortiz
L, Rodriguez-Sanchez
E,
et al. The relationship of the Atlantic diet with cardiovascular risk factors and markers of arterial stiffness in adults without cardiovascular disease.
Nutrients. 2019;11(4):1-13. doi:
10.3390/nu11040742
PubMedGoogle ScholarCrossref 6.Calvo-Malvar
M, Benítez-Estévez
AJ, Sánchez-Castro
J, Leis
R, Gude
F. Effects of a community-based behavioral intervention with a traditional Atlantic diet on cardiometabolic risk markers: a cluster randomized controlled trial (“The Galiat study”).
Nutrients. 2021;13(4):1211. doi:
10.3390/nu13041211
PubMedGoogle ScholarCrossref 8.Calvo-Malvar
MdM, Leis
R, Benítez-Estévez
AJ, Sánchez-Castro
J, Gude
F. A randomised, family-focused dietary intervention to evaluate the Atlantic diet: the GALIAT study protocol.
BMC Public Health. 2016;16(1):820. doi:
10.1186/s12889-016-3441-y
PubMedGoogle ScholarCrossref 9.Calvo-Malvar
M, Benítez-Estévez
AJ, Leis
R, Sánchez-Castro
J, Gude
F. Changes in dietary patterns through a nutritional intervention with a traditional Atlantic diet: the Galiat randomized controlled trial.
Nutrients. 2021;13(12):4233. doi:
10.3390/nu13124233
PubMedGoogle ScholarCrossref 11.Hoffmann
TC, Glasziou
PP, Boutron
I,
et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
BMJ. 2014;348:g1687. doi:
10.1136/bmj.g1687
PubMedGoogle ScholarCrossref 12.Bush
K, Kivlahan
DR, McDonell
MB, Fihn
SD, Bradley
KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.
Arch Intern Med. 1998;158(16):1789-1795. doi:
10.1001/archinte.158.16.1789
PubMedGoogle ScholarCrossref 15.National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
Circulation. 2002;106(25):3143-3421. doi:
10.1161/circ.106.25.3143
PubMedGoogle ScholarCrossref 16.Ortega
RM, López
AM, Carvajales
PA, Requejo
AM, Aparicio
A, Molinero
LM. Programa Dial v. 3.3.5.0. 2016.
17.International Organization for Standardization. Environmental Management-Life Cycle Assessment. International Organization for Standardization; 2006.
18.Esteve-Llorens
X, Darriba
C, Moreira
MT, Feijoo
G, González-García
S. Towards an environmentally sustainable and healthy Atlantic dietary pattern: life cycle carbon footprint and nutritional quality.
Sci Total Environ. 2019;646:704-715. doi:
10.1016/j.scitotenv.2018.07.264
PubMedGoogle ScholarCrossref 21.Gustavsson
J, Cederberg
C, Sonesson
U, Emanuelsson
A. The methodology of the FAO study: “Global Food Losses and Food Waste - extent, causes and prevention” - FAO, 2011. Food and Agriculture Organization of the United Nations; 2013. Accessed December 22, 2023.
https://www.fao.org/3/i2697e/i2697e.pdf 26.United Nations. Transforming Our World: The 2030 Agenda for Sustainable Development. Department of Economic and Social Affairs, United Nations; 2015.
27.Van Gaal
LF, Wauters
MA, De Leeuw
IH. The beneficial effects of modest weight loss on cardiovascular risk factors.
Int J Obes Relat Metab Disord. 1997;21(suppl 1):S5-S9.
PubMedGoogle Scholar 31.Fernández-Bergés
D, Cabrera de León
A, Sanz
H,
et al. Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study.
Rev Esp Cardiol (Engl Ed). 2012;65(3):241-248. doi:
10.1016/j.rec.2011.10.017
PubMedGoogle ScholarCrossref 33.United Nations. Appendix: transforming our world: the 2030 agenda for sustainable development. In: Rosa
W, ed.
A New Era in Global Health: Nursing and the United Nations 2030 Agenda for Sustainable Development. Springer; 2018. doi:
10.1891/9780826190123.ap02